FDA inspection
Elaiapharm: FDA inspection ending Jan 30, 2026
FDA inspection 1301450 · Valbonne
Key facts
| Inspection ID | 1301450 |
|---|---|
| Firm | Elaiapharm |
| FEI number | 3005659648 |
| Address | Zone Industrielle Bouillides, 2881 Route Des Cretes |
| City | Valbonne |
| Fiscal year | 2026 |
| Inspection end date | Jan 30, 2026 |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data